Dr. Bojana Von Sass, Mba Email and Phone Number
Dr. Bojana Von Sass, Mba work email
- Valid
- Valid
- Valid
Dr. Bojana Von Sass, Mba personal email
Dr. Bojana Von Sass, Mba phone numbers
Passionate about serving patients all over the world and committed to the Business of Life. Able to re-energize legacy Brands and bring them back on a sustainable growth path. Capable of generating true new enthusiasm across organizations, mobilizing forces and leading teams to superior performances.I was able to build a winning team around the newly established Therapeutic Area Respiratory for EPD and turn around Klacid, bringing the Brand to overperform the market two consecutive years in a row in all key affiliates. Influvac franchise was rejuvenated, launch of Influvac Tetra well prepared and tracked by close cross-functional collaboration and seamlessly executed, rendering impactful growth. Working together with a cross-functional team I have created and championed the strategy for portfolio expansion into Asthma & COPD.During my time with Sandoz and Hemopharm I also had the opportunity to pioneer and build from scratch by discovering untapped sources of business, introducing new products, influencing internal as well as external stakeholders and creating strong performing new teams, always unleashing further growth.I thrive when given the opportunity to make a difference in an international environment facing complex challenges working together with an energized team.Pharmaceutical industry Leader with experience in managing BU, Sales, Team, Portfolio and Launches: Rx, vaccines and OTC with strong cross cultural communication skills and extensive expertise in Emerging Markets. Creative and imaginative self-starter who welcomes and manages change.
-
Business ConsultantFreelanceFrankfurt, He, De
-
Chief Business OfficerAquilon Pharma Oct 2023 - Present
-
Director Portfolio Management SpecialtiesStada Arzneimittel Ag Mar 2020 - Sep 2023Bad Vilbel, Hesse-Defining and implementing the global Specialty portfolio strategy targeting Value Added Medicines, Hard to Make gx and innovative Orphan and Rare disease therapies- Establishing and developing the Global Portfolio Specialty team of 5 Portfolio managers- Creating a robust Specialty pipeline by identifying, evaluating and securing the right opportunities for Stada future portfolio -
Director, Global Ta Head Respiratory And InfluvacAbbott Mar 2015 - Dec 2019Basel Area, Switzerland- Brand building: full accountability to shape and drive Therapeutic Area Respiratory Marketing Strategy- Defining and building core legacy Brands, Klacid and Influvac, rejuvenating the strategy and setting critical success factors, ensuring that both Brands are healthy and thriving- Product Management: designing and executing medico-marketing programs, initiatives and campaigns to maximize the Brand equity of the core Brands through HCP engagement- Portfolio expansion: foster cross functional collaboration for product innovation and LCM for anti-infectives, influenza and allergic rhinitis; creation of portfolio strategy plan to expand into Asthma & COPD- People: Successful creation of high engagement teams that helped return core legacy Brands to the growth trajectory in all key markets- Launch Influvac Tetra successfully across the EPD geographical footprintAchievements: Klacid, legacy anti-infective mature Brand overperforming the market in all key markets for two consecutive years enabled by implementing a very efficient targeting and segmentation campaign based on prescribing personas as well as reinvigorated enthusiasm among the affiliate sales and marketing teams. Launch of Influvac Tetra executed successfully in LatAm, APAC, India and the Middle East contributing to a high double digit growth of the vaccines franchise vs. plan as well as vs. previous year. -
Head Of Regional Portfolio ApacSandoz Oct 2013 - Mar 2015Munich Area, GermanyCreating robust Portfolio strategy to expand affiliates product range, enabling new product launches and sales growth in targeted Therapeutic Areas across the APAC Region:- Building strong relationships with global D&R functions securing execution of agreed product pipeline- Developing Winning Portfolios for each affiliate based on their core strenghts and market needs- Driving affiliate D&R spent towards the most profitable products and TAs- Managing launch readiness for up to 70 new product launches per year across the RegionKey achievement: Through creation and implementation of the right product selection criteria and a robust D&R strategy, the affiliates were able to expand their product offering into new Therapeutic Areas, like CVM, Oncology, CNS, Men‘s Health and Respiratory. Net sales more than doubled for APAC from ca. $ 300 MM end of 2008 to over $ 800 MM end of 2014, marking 2014 as the best year ever for APAC. -
Commercial Operations Manager ApacSandoz International Gmbh Jan 2007 - Oct 2013Munich Area, GermanyStarted off as Commercial Operations Leader in charge of Canada, Turkey and SEA cluster, focusing on co-creation and implementation of portfolio processes and strengthening affiliate performance through portfolio expansion.Following the geo-reorganization end of 2008, from January 2009 onward part of the Regional APAC management team as Commercial Operations Manager APAC in charge of China, Australia, S. Korea, Philippines, Thailand, Taiwan, Hong Kong, Singapore, Malaysia, Vietnam, Myanmar and Cambodia- Leverage cross-functional networks to secure affiliate portfolio expansion across different Therapeutic Areas- Launch readiness management- Development of the 5Y Strategic plan- Active participation in annual budget preparation
-
Head Of The Otc BuHemopharm Gmbh Oct 2000 - Aug 2006Frankfurt Area, GermanyTransformed the affiliate by creating a completely new BU for marketing and selling own branded OTC products into the German market (up to that point only API trade):Responsible for market entry strategy, portfolio selection and sourcing as well as the introduction of own branded OTC portfolio to German pharmacies, accountable for: 1. Establishing a Business Plan for the sales of the own branded OTC product range 2. Product positioning, defining the marketing mix, creation and implementation of POS marketing activities 3. Defining the org. structure and responsible for hiring, training and evaluating performance of 10+ sales reps 3. Marketing & Sales responsibility including portfolio definition, planning and implementation.Achievements: Within a start-up-like environment, successfully established a new player with a branded generic OTC portfolio in the German market. Launched 10 products from 2002 until 2006 with sales steadily growing to reach € 20 MM by 2015.OTC Products tech-transfer to the HQ triggered GMP certification by the UK, German as well as also US authorities (FDA), enabling Hemofarm group to establish itself as a competitive tool manufacturer going further. -
Academic Assistant To A Member Of The German Parliament, Mr. Hans-Peter RepnikThe German Parliament Jun 1999 - Jun 2000Working for the team of Mr. Hans-Peter Repnik, who at the time was the first Parliament Leader of the CDU/CSU Bundestagsfraktion, I was focusing on research and doing reporting on the War in the Balkans.
-
Head Of The Ip DepartmentHemofarm Feb 1995 - May 1999SerbiaAfter a brief tenure within the Legal Dpt., I was tasked with establishing the IP department from scratch:Defining the org. structure, putting in place processes to manage existing assets and setting up of a network of patent attorneys in various export markets. Given the rising importance of IP and License agreements in the challenging political environment, it was important to raise awareness and educate internally, hence I drafted and implemented the company's negotiating strategy for licensing. I was responsible for drafting, negotiation, conclusion, registration and overseeing the implementation with license partners.Key achievements were signing of the exclusive License agreements with GSK for Zofran and Fortum as well as purchase of a list of the Tradenames from at the time Goedecke/ Parke Davis licensing agreements from 1970-ties, enabling Hemofarm to continue marketing the iconic Brands in its territories.
Dr. Bojana Von Sass, Mba Skills
Dr. Bojana Von Sass, Mba Education Details
-
Innovation And New Business Creation -
International Public Law And Patent Law -
Education "Business Strategy" Program -
International Public Law
Frequently Asked Questions about Dr. Bojana Von Sass, Mba
What company does Dr. Bojana Von Sass, Mba work for?
Dr. Bojana Von Sass, Mba works for Freelance
What is Dr. Bojana Von Sass, Mba's role at the current company?
Dr. Bojana Von Sass, Mba's current role is Business Consultant.
What is Dr. Bojana Von Sass, Mba's email address?
Dr. Bojana Von Sass, Mba's email address is bo****@****ovic.eu
What is Dr. Bojana Von Sass, Mba's direct phone number?
Dr. Bojana Von Sass, Mba's direct phone number is +122466*****
What schools did Dr. Bojana Von Sass, Mba attend?
Dr. Bojana Von Sass, Mba attended Technische Universität München, Ruhr-Universität Bochum, Columbia Business School, Ruhr-Universität Bochum.
What skills is Dr. Bojana Von Sass, Mba known for?
Dr. Bojana Von Sass, Mba has skills like Pharmaceutical Industry, Regulatory Affairs, Portfolio Management, Cross Functional Team Leadership, Business Planning, Business Development, Strategy, Market Analysis, Pharmaceutical Sales, Management, Product Launch, Launch Management.
Who are Dr. Bojana Von Sass, Mba's colleagues?
Dr. Bojana Von Sass, Mba's colleagues are Sandrine Bekaert, Natacha Rocks, Damien Thiéry, Sandrine Bekaert, Frank Pieters, Loris D'antuono.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial